
Sign up to save your podcasts
Or
Synthetic biologists are hard at work developing artificial biological molecules as the first step toward developing a mirror cell that would be immune from infection. If they're successful, it could transform the world of medicine. But while the potential of mirror life is great, so too are the risks. There are warnings of a catastrophic impact if the cells can't be controlled. And that's prompted calls for a moratorium on the research.
Guests
Associate Professor Kate Adamala — Synthetic biologist and professor of genetics, University of Minnesota
Professor Andrew Ellington — Center for Systems and Synthetic Biology, University of Texas at Austin
Professor Heather Douglas — Department of Philosophy, Michigan State University
Ajay Kshatriya — CEO Aizen Therapeutics
4.4
6161 ratings
Synthetic biologists are hard at work developing artificial biological molecules as the first step toward developing a mirror cell that would be immune from infection. If they're successful, it could transform the world of medicine. But while the potential of mirror life is great, so too are the risks. There are warnings of a catastrophic impact if the cells can't be controlled. And that's prompted calls for a moratorium on the research.
Guests
Associate Professor Kate Adamala — Synthetic biologist and professor of genetics, University of Minnesota
Professor Andrew Ellington — Center for Systems and Synthetic Biology, University of Texas at Austin
Professor Heather Douglas — Department of Philosophy, Michigan State University
Ajay Kshatriya — CEO Aizen Therapeutics
211 Listeners
111 Listeners
129 Listeners
94 Listeners
16 Listeners
51 Listeners
30 Listeners
1,714 Listeners
892 Listeners
757 Listeners
140 Listeners
25 Listeners
70 Listeners
51 Listeners
69 Listeners
325 Listeners
720 Listeners
132 Listeners
12 Listeners
196 Listeners
112 Listeners
242 Listeners
42 Listeners